Amalgamated Bank Entrada Therapeutics, Inc. Transaction History
Amalgamated Bank
- $12.1 Billion
- Q3 2024
A detailed history of Amalgamated Bank transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 721 shares of TRDA stock, worth $9,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
721
Previous 721
-0.0%
Holding current value
$9,610
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$64.9 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$59 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$58.8 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$40.7 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$22.8 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $418M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...